The Drugs Controller General of India (DCGI) has declared as many as 16 commonly-used medicines as spurious, after they ...

The Nifty Pharma has gained around 37% year to date. The growth continues to be led by the US sales and well supported by ...

Orchid Pharma's new Antimicrobial Solutions division aims to achieve a turnover of Rs 300 crore in three years, tackling ...

The Nifty 50 is expected to remain rangebound before moving in a firm direction. Below are some trading ideas for the near ...

India faces a rising concern as diabetes increasingly links to neurodegenerative diseases like dementia and Alzheimer’s. With ...

Prime Minister Narendra Modi is expected to inaugurate a new Penicillin-G plant in Andhra Pradesh, marking the revival of domestic production after three decades. Hyderabad-based Aurobindo Pharma will ...

Mankind Pharma Ltd. will raise up to Rs 10,000 crore via issue of debt instruments. The board on Friday approved the plan to raise funds through non-convertible debentures and commercial papers on a ...

Indian shares are set to open higher on Friday, as an outsized interest rate reduction by the U.S. Federal Reserve and the ...

Mankind Pharma's strategic partnership with Bharat Serums and Vaccines poised for significant growth potential.

Govt defends land acquisition for Hyderabad Pharma CityRevenue Principal Secretary Navin Mittal submitted a counter affidavit ...

Merck and Daiichi Sankyo's HER3 antibody-drug conjugate reported a positive phase 3 result in EGFR-mutated lung cancer. Merck ...

After achieving about 10 per cent growth last year, the Indian pharmaceuticals sector is again set to log a revenue growth of 8-10 per cent this fiscal, according to a report on Wednesday. The report ...